4,6-Dibromodibenzofuran

We are 4,6-Dibromodibenzofuran CAS:201138-91-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4,6-Dibromodibenzofuran
CAS.NO:201138-91-2
Synonyms:4,6-dibromo-dibenzofurane
Dibenzofuran,4,6-dibromo
4,6-Dibromodibenzo[b,d]furan
Molecular Formula:C12H6Br2O
Molecular Weight:325.98300
 
Physical and Chemical Properties:
Density:1.886
Boiling point:396.049ºC
Flash point:193.324ºC
 
Specification:
Appearance:Off-white powder
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates

4,6-Dibromodibenzofuran


Related News: In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC.4-Amino-3-chlorophenol hydrochloride CAS:52671-64-4 Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.4-Dimethylaminopyridine Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.1-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)piperazine At the same time, because the profits of a single variety of characteristic APIs do not have long-term growth, companies need more product reserves.Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).

Related Products
Product Name
3-Morpholino-5,6-dihydropyridin-2(1H)-one View Details
6-(Trifluoromethyl)nicotinic acid View Details
Sincalide View Details
2-((6-Chloro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile manufacturer Benzenesulfinic Acid Sodium Salt manufacturer 7-methoxy-6-(3-morpholin-4-ylpropoxy)-1H-quinazolin-4-one manufacturer (R)-(3-(3-Fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl methanesulfonate manufacturer Azepane manufacturer